StockNews.AISignal intelligence
Company intelligence

TCNNF

TCNNF

PriceLatest market price
Market capEquity value
P / ETrailing ratio
VolumeLatest session
Market data

TCNNF price chart

TradingView
Related signals
1 min delayed

Browse public TCNNF signals with their source context and measured market impact. Open any signal for its permanent analysis page.

TCNNFJun 10, 20260.00% since signal

Trulieve NYSE Debut Highlights Uplisting Tailwinds for US Cannabis

Trulieve begins trading on the NYSE as TRLV, moving from OTC TCNNF and CSE TRUL. The company attributes the listing to Schedule III reclassification and a strategic separation of medical versus adult-use operations. A June DEA hearing could further loosen federal cannabis restrictions, potentially broadening institutional access and re-shaping the competitive landscape for TCNNF and peers.

View signal analysis
TCNNFFeb 26, 2025+5.30% since signal

Trulieve, Curaleaf and Green Thumb launch hemp-based THC drinks as cannabis reforms stall - MarketWatch

Trulieve launched a premium THC beverage line, enhancing its product offerings. Analysts predict a $14 billion growth potential for hemp-derived THC beverages. Regulatory clarity is sought for low-THC beverages under U.S. farm bill. Competition includes major companies like Curaleaf and Tilray in the beverage market. Hemp-derived THC provides additional revenue as cannabis legalization efforts stall.

View signal analysis
TCNNFAug 6, 2024+10.40% since signal

Cannabis retailer Trulieve posts narrower Q2 loss as revenue tops $300 million - MarketWatch

Trulieve narrowed losses to $12 million with increased revenue of 8%. Company's gross margins expanded to 60% from 50%, outperforming analyst expectations. Trulieve opened three new adult-use stores in Ohio, enhancing market presence. The stock increased by 66% in 2024, showcasing strong performance amid market challenges. CEO Kim Rivers highlights significant growth catalysts and market position.

View signal analysis
Research

Company intelligence